CLN-049 is a T cell engaging bispecific antibody that targets FTL3 on cancer cells, and CD3 on T cells. It is being studied for use in different cancers.
| SparkCures ID | 628 |
|---|---|
| Generic Name | CLN-049 |
| Treatment Targets |
|
There are no resources, links or videos to display for this treatment.